Effect of subtherapeutic concentrations of tylosin on the inhibitory stringency of a mixed anaerobe continuous-flow culture of chicken microflora against Escherichia coli O157:H7

In Vitro Evaluation of the Effects of Tylosin on the Composition and Metabolism of Canine Fecal Microbiota

Simple Summary

The antibiotic-responsive enteropathy is a common canine chronic disorder for which tylosin represents an effective widely used therapeutic option, although its mechanism of action, beyond the well-known antibacterial activity, is still unclear. Given the beneficial role of prebiotic substrates for gut health, positive outcomes deriving from the association of tylosin with some prebiotic oligosaccharides might be supposed. The present study investigated in vitro the effects of tylosin, alone or supplemented with fructooligosaccharides, galactooligosaccharides, or xylooligosaccharides, on the composition and activity of the fecal microbiota of healthy dogs. It was partially confirmed that the antibacterial effect of tylosin, given the reduction of some microbial populations and metabolites, e.g., volatile fatty acids. Interestingly, the association of tylosin with prebiotics revealed counteracting effects on some undesirable changes exerted by tylosin, e.g., the reduction of bacteria generally considered beneficial such as lactobacilli and Clostridium cluster XIVa as well as volatile fatty acids, i.e., microbial fermentative end-products that are recognized as essential for enterocytes homeostasis.

Abstract

The present study investigated the in vitro effects of tylosin (TYL), alone or associated with prebiotics (PRE), on selected canine fecal parameters. Eight treatments were set up: control diet with no addition of substrates; TYL; Fructooligosaccharides (FOS); Galactooligosaccharides (GOS); Xylooligosaccharides (XOS); TYL + FOS; TYL + GOS; TYL + XOS. The flasks (five for treatment), containing a canine fecal suspension (prepared with the feces of healthy adult dogs) and the residue of an in vitro digested dry dog food, were incubated in an anaerobic chamber at 39 °C. TYL and PRE were added at a concentration of 0.2 and 1 g/L, respectively. Samples were collected after 6 and 24 h for analyses. PRE decreased pH values, iso-butyrate, and iso-valerate throughout the incubation; increased lactobacilli, cadaverine, and, tendentiously, total volatile fatty acids after 6 h; increased n-butyrate, putrescine, spermidine, and reduced spermine and E. coli after 24 h. TYL resulted in lower total volatile fatty acids and lactobacilli and higher Clostridium cluster I after 6 h and higher pH values, spermidine, and E. coli throughout the study. When associated with TYL, PRE counteracted some undesirable effects of the antibiotic such as the decrease of lactobacilli and Clostridium cluster XIVa at both 6 and 24 h. In the present study, TYL exhibited inhibitory effects on canine fecal microbiota partially counteracted by PRE supplementation.

Ecology of Enterococcus faecalis and niche-adapted or non-niche-adapted Enterococcus faecium in continuous-flow anaerobic cultures

An anaerobic continuous-flow culture of chicken gastrointestinal microflora (CCF) and pure cultures of Enterococcus faecalis I.2 were used for survivability studies of niche-adapted and non-niche-adapted Enterococcus faecium isolates. CCF eliminated non-CCF niche-adapted glycopeptide-resistant E. faecium 47 (GRE47) at a rate of 1.01 log(10) cfu/mL/day, whereas CCF niche-adapted E. faecium I.3(rif) survived in CCF at 4.5-6.5 log(10) cfu/mL. In continuous-flow monocultures of GRE47 (8.93 log(10) cfu/mL), the addition of 100 mL (9.5% total volume) of CCF resulted in the displacement of GRE47 in 14 days at a rate of 0.66 log(10) cfu/mL/day. Pure continuous-flow cocultures were used to assess a direct inhibitory effect of E. faecalis I.2 on E. faecium isolates. In cocultures of E. faecalis I.2 and GRE47, GRE47 was eliminated from the culture at a rate of 1.24 log(10) cfu/mL/day. In cocultures of E. faecalis I.2 and E. faecium I.3(rif), the E. faecium I.3(rif) population fluctuated, but was 6.86 log(10) CFU/mL on day 21. A fit subset of the E. faecium I.3(rif) population survived in CCF and with E. faecalis I.2 alone. No subset of the non-niche-adapted E. faecium GRE47 was able to survive under the same conditions. The mechanism by which E. faecium I.3(rif) is tolerant in CCF, and in E. faecalis coculture is unknown. E. faecium I.3(rif) and GRE47 possessed the cell wall adhesion factor efaAfm. E. faecalis I.2 was positive by polymerase chain reaction for gelE, efaAfs, cad, ccf, cdp, and cob, but not the cytolysin-associated gene cylMAB, suggesting that the mechanism of activity against E. faecium strains was due to factors other than the two-component cytolysin.

A comparative study on the effects of tylosin on select bacteria during continuous flow culture of mixed populations of gut microflora derived from a feral and a domestic pig

Continuous flow cultures of feral (culture FC) and domesticated (culture RPCF) pig gut microflora were established in steady state. Cultures were continuously infused with 25 or 100 microg tylosin/mL and sampled at intervals to assess effects on total culturable anaerobes, Bacteroides and Enterococcus via plating to agar supplemented without or with 100 microg tylosin/mL, the latter to assess bacterial sensitivity to tylosin. Endogenous tylosin-insensitive anaerobes within the cultures, while similar prior to tylosin administration, responded differently during tylosin administration, with concentrations in RPCF cultures becoming enriched more than in FC cultures. Tylosin-insensitive anaerobes in RPCF cultures persisted at increased concentrations after cessation of tylosin administration whereas concentrations in FC cultures decreased slightly. Concentrations of Bacteroides and endogenous Enterococcus recovered on medium without tylosin decreased to near or below detectable levels in FC cultures administered 25 or 100 microg tylosin/mL. Tylosin-insensitive Bacteroides were enriched to >5 log10 CFU/mL in RPCF cultures after 25 microg tylosin/mL but not at 100 microg tylosin/mL. Populations of endogenous tylosin-insensitive Enterococcus were enriched in RPCF but not FC cultures administered 25 or 100 microg tylosin/mL. In cultures administered 100 microg tylosin/mL, an exogenous-sourced E. faecium possessing tylosin resistance maintained itself only in the presence of tylosin. These results indicate that under the conditions of these tests, antibiotic exposure may enrich for antibiotic-insensitive bacteria populations of endogenous or exogenous origin but that the ability of an exogenous tylosin-resistant E. faecium to persist is reduced in the absence of the antibiotic, likely due to exclusion by native flora.

Shedding of escherichia coli O157:H7 by cattle fed diets containing monensin or tylosin

Monensin and tylosin have activity against gram-positive bacteria, and it has been theorized that their effects on the intestinal environment may promote proliferation of gram-negative bacteria such as Escherichia coli. Effects of these antibiotics on the shedding of E. coli O157:H7 were studied in a feedlot environment, using 32 finishing steers. A diet containing 85% barley grain, 10% barley silage, and 5% supplement was amended with 33 ppm monensin, 11 ppm tylosin, both of these additives, or no additives (control). All steers were orally inoculated with 10(10) CFU of a mixture of four strains of nalidixic acid-resistant E. coli O157:H7. Fecal (grab), oral (mouth swab) and water, water-water bowl interface, feed, and pen floor fecal pat samples were collected weekly for 12 weeks. Prevalence of E. coli O157:H7-positive fecal grab samples did not differ (P = 0.26) among treatments, nor did the rate (P = 0.81) or duration (P = 0.85) of shedding of the organism. Fecal grab samples were positive for E. coli O157:H7 more frequently (P < 0.001) than were oral swabs. More (P = 0.02) E. coli O157:H7-positive oral swabs were recovered from the tylosin group than from controls. E. coli O157:H7 was not detected in any of 47 water samples, but was present in 1 of 47 water bowl swabs, 7 of 48 feed samples, and 36 of 48 fecal pats. Pulsed-field gel electrophoresis suggested that differences existed among inoculated strains in their ability to persist in animals and in the environment. However, this study revealed no evidence that dietary inclusion of monensin or tylosin, alone or in combination, increased fecal shedding of E. coli O157:H7 or its persistence in the environment.

Competitive Exclusion of a Glycopeptide-Resistant Enterococcus Faecium in the Presence of Vancomycin but not Equivalent Concentrations of Tylosin or Gentamicin

The effect of subtherapeutic concentrations of antibiotics (10.0 and 40.0 microg/mL of vancomycin, gentamicin, and tylosin) on the efficacy of a mixed anaerobe culture of chicken microflora (CCF) was studied in a continuous-flow fermentation system. Efficacy of CCF posttreatment was assessed by challenge with glycopeptide-resistant Enterococcus faecium (GRE) at 6.0 log10 cfu/mL. Bacterial enumeration of endogenous CCF isolates, volatile fatty acid (VFA) analysis, and challenge with GRE indicated that CCF efficacy was affected by all antibiotic treatments. Although CCF treated with 10.0 microg/mL of vancomycin eliminated GRE13 at a rate of 0.61 log10 cfu/ mL per day, it was unable to eliminate E. coli, a gram-negative challenge organism. All other antibiotic treatments allowed GRE persistence at approximately 2.0 to 6.5 log10 cfu/mL. All antibiotic-treated cultures had decreased concentrations of acetic and propionic acids. Our data suggest that low concentrations of antimicrobials may adversely affect the microbial ecology of gut microflora with respect to its ability to exclude exogenous bacteria. Moreover, gentamicin had an adverse effect on the inhibitory stringency of CCF even though it showed little anti-anaerobic activity against CCF strict anaerobes in pure culture. Verification of the results in live animals will be necessary to determine if antimicrobial treatment could compromise the effectiveness of normal microflora to serve as a natural host defense against infection.